Table 1 Demographic features, risk factors, stroke classification, clinical assessment, and procedures of ATHS, CES and control group.
Demographic features and risk factors | ATHS (n = 18) | CES (n = 14) | Controls (n = 30) |
|---|---|---|---|
Age, median (yr, IQR)‡ | 69.2 (11) | 73.6 (10) | 71.2 (10) |
Gender, female, n (%)† | 11 (61) | 7 (50) | 19 (63) |
Risk Factors | |||
Hypertension, n (%)† | 15 (83) | 11 (79) | 22 (73) |
Diabetes mellitus, n (%)† | 10 (56) | 9 (64) | 15 (50) |
Hyperlipidaemia, n (%)† | 8 (44) | 7 (50) | 11 (37) |
Cigarette smoking, n (%)† | 7 (39) | 6 (42) | 11 (37) |
Treatments | |||
Antiplatelet therapy prior to stroke, n (%)† | 10 (56)1 | 4 (29)1 | 11 (37) |
Anticoagulant therapy prior to stroke, n (%)† | 0 (0)1 | 9 (64)1,2 | 0 (0)2 |
OCSP1 classification | |||
ACI, n (%)† | 9 (50) | 7 (50) | NA |
POCI, n (%)† | 3 (17) | 3 (21) | NA |
LACI, n (%)† | 0 (0) | 0 (0) | NA |
TACI, n (%)† | 6 (33) | 4 (0) | NA |
Clinical assessment and procedures | |||
NIHSS at stroke onset, median (IQR)§ | 12.4 (8) | 11.8 (9) | NA |
NIHSS after discharge, median (IQR)§ | 4.2 (6) | 2 (5) | NA |
GCS at stroke onset, median (IQR)§ | 14 (2) | 15 (1) | NA |